AstraZeneca is no longer pursuing plans for a 450 million pound ($558.32 million) vaccine manufacturing plant in Speke, Liverpool, a company spokesperson said on Friday.
The green light from the European Medicines Agency is the first backing in the EU for the medicine, following its approval in ...